CPRIT Product Development Research Awards
Varies by active product-development award mechanism · Cancer Prevention and Research Institute of Texas
CPRIT Product Development Research Awards is a grant programme from Cancer Prevention and Research Institute of Texas for Texas-based or Texas-relocating companies and institutions developing cancer products under an open CPRIT mechanism Current lifecycle: closed. Real economics: Varies by active product-development award mechanism.
Tier 3governmenttexashealthcancer
ApplyOfficial siteOpen in the live directory
Key facts
| Funder | Cancer Prevention and Research Institute of Texas |
| Amount | Varies by active product-development award mechanism |
| Decision time | No dependable comparable application-to-decision interval was published in the reviewed public corpus. |
| Eligibility | Texas-based or Texas-relocating companies and institutions developing cancer products under an open CPRIT mechanism |
| Restrictions | Awardees should expect agreement, milestone, expenditure, progress and final reporting plus record-retention or audit obligations; the executed terms control. Support is restricted to the approved project, research, prototype, commercialization, personnel, equipment, vendor or programme costs; unsupported and duplicate-funded costs are excluded. |
| Status | closed |
Always confirm on the official page before applying — dates and terms change.
Application process
- Confirm the current call and fit
- Review eligibility and exclusions
- Prepare applicant, project, budget and impact evidence
- Submit through the official route
- Complete merit and due-diligence review
- Execute award terms and milestones if selected
Background
Cancer Prevention and Research Institute of Texas operates CPRIT Product Development Research Awards. This pass separates direct cash, repayable finance, credits, incentives and umbrella programs so later ranking does not compare unlike instruments. The official sponsor maintains this instrument for eligible Texas applicants or globally eligible teams. The published eligibility describes Texas-based or Texas-relocating companies and institutions developing cancer products under an open CPRIT mechanism. Public award economics are call-specific and were not converted into an unsupported cash estimate.
How the application really works
Confirm the current call and fit → Review eligibility and exclusions → Prepare applicant, project, budget and impact evidence → Submit through the official route → Complete merit and due-diligence review → Execute award terms and milestones if selected
Tips
- Show direct fit with innovation.
Watch out for
- Current lifecycle is closed.
- Awardees should expect agreement, milestone, expenditure, progress and final reporting plus record-retention or audit obligations; the executed terms control.
- Support is restricted to the approved project, research, prototype, commercialization, personnel, equipment, vendor or programme costs; unsupported and duplicate-funded costs are excluded.
Track record
- The official sponsor maintains this instrument for eligible Texas applicants or globally eligible teams.
- The published eligibility describes Texas-based or Texas-relocating companies and institutions developing cancer products under an open CPRIT mechanism.
- Public award economics are call-specific and were not converted into an unsupported cash estimate.
The reviewed official corpus does not publish a comparable applicant denominator and acceptance rate for the next call.
Frequently asked questions
- Is this actionable now?
- closed. Official programme materials were reviewed on 2026-08-10; applicants must verify the next live cycle and controlling solicitation before committing application effort.
- What is the real economic value?
- Varies by active product-development award mechanism
- Who is eligible?
- Texas-based or Texas-relocating companies and institutions developing cancer products under an open CPRIT mechanism
- How does selection work?
- Confirm the current call and fit; Review eligibility and exclusions; Prepare applicant, project, budget and impact evidence; Submit through the official route; Complete merit and due-diligence review; Execute award terms and milestones if selected. No dependable comparable application-to-decision interval was published in the reviewed public corpus.
- What burden and restrictions apply?
- Awardees should expect agreement, milestone, expenditure, progress and final reporting plus record-retention or audit obligations; the executed terms control. Support is restricted to the approved project, research, prototype, commercialization, personnel, equipment, vendor or programme costs; unsupported and duplicate-funded costs are excluded.
- What evidence exists?
- The official sponsor maintains this instrument for eligible Texas applicants or globally eligible teams. The published eligibility describes Texas-based or Texas-relocating companies and institutions developing cancer products under an open CPRIT mechanism. Public award economics are call-specific and were not converted into an unsupported cash estimate. The reviewed official corpus does not publish a comparable applicant denominator and acceptance rate for the next call.
Related grants
Sources
- www.cprit.texas.gov/grants-funded/grant-process/product-development-research — Official programme page reviewed for eligibility, economics, lifecycle and application route (checked 2026-08-10)
- www.cprit.texas.gov — Official administering-organization site reviewed for ownership and current context (checked 2026-08-10)